axonal guidance proteins (Acorda)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameaxonal guidance proteins (Acorda)
Drug Alias Namematrix modifiers (Acorda)tenacin-C glycoprotein (Acorda)L1 axonal guidance proteins (Acorda)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules modulators
TargetsCell adhesion molecules
Therapy Area/IndicationsSpinal Cord InjuriesParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcorda Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcorda Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSpinal Cord InjuriesParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A